| scholarly article | Q13442814 |
| P50 | author | George A. Calin | Q64785850 |
| Ioana Berindan-Neagoe | Q87613611 | ||
| Cristina-Sorina Cătană | Q108750282 | ||
| P2860 | cites work | miR-519 suppresses tumor growth by reducing HuR levels | Q41764008 |
| MicroRNAs as Molecular Targets for Cancer Therapy: On the Modulation of MicroRNA Expression. | Q41974673 | ||
| Specific microRNAs regulate heat stress responses in Caenorhabditis elegans | Q43179779 | ||
| Circulating microRNAs in aging | Q43185693 | ||
| miR-181a is associated with poor clinical outcome in patients with colorectal cancer treated with EGFR inhibitor | Q44077666 | ||
| MicroRNA-34a inhibits uveal melanoma cell proliferation and migration through downregulation of c-Met. | Q53436700 | ||
| Diagnostic potential of PTEN-targeting miR-214 in the blood of breast cancer patients. | Q53659259 | ||
| Circulating MicroRNAs as Biomarkers and Mediators of Cell-Cell Communication in Cancer. | Q53845923 | ||
| Physiology. The tick-tock of aging? | Q82063412 | ||
| Tumor suppressor effect of the microRNA miR-519 is mediated via the mRNA-binding protein HuR | Q84078382 | ||
| Hallmarks of Cancer: The Next Generation | Q22252312 | ||
| miR-9, a MYC/MYCN-activated microRNA, regulates E-cadherin and cancer metastasis | Q24613599 | ||
| MicroRNA expression profiling of human breast cancer identifies new markers of tumor subtype | Q24646090 | ||
| Coordinate regulation of FOXO1 by miR-27a, miR-96, and miR-182 in breast cancer cells | Q24649127 | ||
| The critical roles of miR-21 in anti-cancer effects of curcumin | Q26770490 | ||
| Roles for miRNAs in endocrine resistance in breast cancer | Q26783076 | ||
| Noncoding RNA control of cellular senescence | Q26786557 | ||
| Exploring miRNA-Associated Signatures with Diagnostic Relevance in Glioblastoma Multiforme and Breast Cancer Patients | Q26796590 | ||
| Phytochemicals modulate carcinogenic signaling pathways in breast and hormone-related cancers | Q26798324 | ||
| MicroRNAs: New Biomarkers for Diagnosis, Prognosis, Therapy Prediction and Therapeutic Tools for Breast Cancer | Q26801108 | ||
| Mechanisms of endocrine resistance in breast cancer: an overview of the proposed roles of noncoding RNA | Q27011221 | ||
| MicroRNA signatures in human cancers | Q27860962 | ||
| MicroRNAs in breast cancer: oncogene and tumor suppressors with clinical potential | Q28081081 | ||
| Characterization of the 13q14 tumor suppressor locus in CLL: identification of ALT1, an alternative splice variant of the LEU2 gene | Q28216381 | ||
| Posttranscriptional regulation of cancer traits by HuR | Q28248667 | ||
| Programmed cell death 4 (PDCD4) is an important functional target of the microRNA miR-21 in breast cancer cells | Q28256740 | ||
| The heterochronic microRNA let-7 inhibits cell motility by regulating the genes in the actin cytoskeleton pathway in breast cancer | Q28283868 | ||
| Registered report: A coding-independent function of gene and pseudogene mRNAs regulates tumour biology | Q28608111 | ||
| Comparative Meta-Analysis of Transcriptomics Data during Cellular Senescence and In Vivo Tissue Ageing | Q30952223 | ||
| Retracted: MiR-145 Regulates Epithelial to Mesenchymal Transition of Breast Cancer Cells by Targeting Oct4 | Q31103041 | ||
| Expression of miR-21 and its targets (PTEN, PDCD4, TM1) in flat epithelial atypia of the breast in relation to ductal carcinoma in situ and invasive carcinoma | Q33454083 | ||
| Canonical Nlrp3 inflammasome links systemic low-grade inflammation to functional decline in aging | Q33595895 | ||
| MicroRNA Machinery Genes as Novel Biomarkers for Cancer | Q33657886 | ||
| Dysregulated miR-183 inhibits migration in breast cancer cells. | Q33698660 | ||
| Identification of novel molecular regulators of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis in breast cancer cells by RNAi screening | Q33739941 | ||
| MicroRNA-21 regulates breast cancer invasion partly by targeting tissue inhibitor of metalloproteinase 3 expression | Q33784804 | ||
| MicroRNA-205 signaling regulates mammary stem cell fate and tumorigenesis. | Q33808330 | ||
| Chronic inflammation (inflammaging) and its potential contribution to age-associated diseases | Q34040980 | ||
| Systematic analysis of metastasis-associated genes identifies miR-17-5p as a metastatic suppressor of basal-like breast cancer. | Q34049023 | ||
| Curcumin, inflammation, ageing and age-related diseases. | Q34102379 | ||
| MicroRNA-155 functions as an OncomiR in breast cancer by targeting the suppressor of cytokine signaling 1 gene | Q34107532 | ||
| Pro-neural miR-128 is a glioma tumor suppressor that targets mitogenic kinases. | Q34159409 | ||
| miR-340 inhibition of breast cancer cell migration and invasion through targeting of oncoprotein c-Met | Q34194306 | ||
| MicroRNA93 regulates proliferation and differentiation of normal and malignant breast stem cells. | Q34299430 | ||
| Novel direct targets of miR-19a identified in breast cancer cells by a quantitative proteomic approach | Q34406228 | ||
| Correlation between Slug transcription factor and miR-221 in MDA-MB-231 breast cancer cells | Q34432552 | ||
| The MUC1 and galectin-3 oncoproteins function in a microRNA-dependent regulatory loop | Q34440854 | ||
| Serum microRNA-155 as a potential biomarker to track disease in breast cancer | Q34447755 | ||
| MicroRNA-155 modulates Treg and Th17 cells differentiation and Th17 cell function by targeting SOCS1 | Q34455072 | ||
| STAT3 induction of miR-146b forms a feedback loop to inhibit the NF-κB to IL-6 signaling axis and STAT3-driven cancer phenotypes | Q34518047 | ||
| Regulation of IGF -1 signaling by microRNAs | Q34936657 | ||
| Dysregulation of microRNAs in breast cancer and their potential role as prognostic and predictive biomarkers in patient management | Q35094742 | ||
| MicroRNA-mediated drug resistance in breast cancer | Q35165126 | ||
| Transcript and protein expression decoupling reveals RNA binding proteins and miRNAs as potential modulators of human aging. | Q35222558 | ||
| Restoration of miR17/20a in solid tumor cells enhances the natural killer cell antitumor activity by targeting Mekk2. | Q35411058 | ||
| miR-24-2 controls H2AFX expression regardless of gene copy number alteration and induces apoptosis by targeting antiapoptotic gene BCL-2: a potential for therapeutic intervention. | Q35559007 | ||
| Inflammaging and cancer: a challenge for the Mediterranean diet | Q35585943 | ||
| MicroRNA changes in human arterial endothelial cells with senescence: relation to apoptosis, eNOS and inflammation. | Q35631669 | ||
| MiR-145 directly targets p70S6K1 in cancer cells to inhibit tumor growth and angiogenesis | Q35672212 | ||
| MicroRNAs and their roles in aging. | Q35714517 | ||
| KSHV MicroRNAs Repress Tropomyosin 1 and Increase Anchorage-Independent Growth and Endothelial Tube Formation | Q35742729 | ||
| Long noncoding RNAs in development and cancer: potential biomarkers and therapeutic targets | Q35747814 | ||
| The role of microRNA-128a in regulating TGFbeta signaling in letrozole-resistant breast cancer cells | Q35808483 | ||
| Association of type and location of BRCA1 and BRCA2 mutations with risk of breast and ovarian cancer | Q35957703 | ||
| MiR-27a modulates radiosensitivity of triple-negative breast cancer (TNBC) cells by targeting CDC27. | Q35994279 | ||
| MiR-145 inhibits tumor angiogenesis and growth by N-RAS and VEGF. | Q36012772 | ||
| A novel multi-tissue RNA diagnostic of healthy ageing relates to cognitive health status | Q36032418 | ||
| Growth inhibition by miR-519 via multiple p21-inducing pathways | Q36210880 | ||
| MTOR regulates the pro-tumorigenic senescence-associated secretory phenotype by promoting IL1A translation | Q36405926 | ||
| Circulating microRNA signature of genotype-by-age interactions in the long-lived Ames dwarf mouse | Q36410036 | ||
| Genomics of chronic lymphocytic leukemia microRNAs as new players with clinical significance | Q36449652 | ||
| MicroRNA control of lifespan and metabolism | Q36455147 | ||
| Blockade of senescence-associated microRNA-195 in aged skeletal muscle cells facilitates reprogramming to produce induced pluripotent stem cells | Q36475238 | ||
| Systemically injected exosomes targeted to EGFR deliver antitumor microRNA to breast cancer cells | Q36512528 | ||
| MicroRNA-10b targets E-cadherin and modulates breast cancer metastasis | Q36577259 | ||
| MicroRNA expression and function in cancer | Q36637333 | ||
| Breast cancer metastasis: a microRNA story | Q36678630 | ||
| Inherited variation in miR-290 expression suppresses breast cancer progression by targeting the metastasis susceptibility gene Arid4b | Q36778032 | ||
| miR-126 and miR-126* repress recruitment of mesenchymal stem cells and inflammatory monocytes to inhibit breast cancer metastasis | Q36902134 | ||
| Circulating inflamma-miRs in aging and age-related diseases | Q36955787 | ||
| Novel MicroRNA Reporter Uncovers Repression of Let-7 by GSK-3β | Q36958666 | ||
| miR-519 reduces cell proliferation by lowering RNA-binding protein HuR levels | Q37068662 | ||
| Serum circulating microRNA profiling for identification of potential breast cancer biomarkers | Q37260646 | ||
| MicroRNAs as Novel Biomarkers for Breast Cancer | Q37267684 | ||
| MiR-124 inhibits the migration and invasion of ovarian cancer cells by targeting SphK1. | Q37427776 | ||
| Non-coding RNAs and cancer: new paradigms in oncology. | Q37859125 | ||
| Small but smart--microRNAs in the centre of inflammatory processes during cardiovascular diseases, the metabolic syndrome, and ageing | Q37945163 | ||
| Effect of microRNA-34a in cell cycle, differentiation, and apoptosis: a review | Q37967610 | ||
| The emerging role of MIR-146A in the control of hematopoiesis, immune function and cancer | Q37997552 | ||
| Clinical applications for microRNAs in cancer | Q38065062 | ||
| Computational experiments reveal the efficacy of targeting CDK2 and CKIs for significantly lowering cellular senescence bar for potential cancer treatment | Q38068723 | ||
| MicroRNAs linking inflamm-aging, cellular senescence and cancer | Q38108083 | ||
| Oxidative stress and vascular inflammation in aging. | Q38121364 | ||
| Immunosenescence in monocytes, macrophages, and dendritic cells: lessons learned from the lung and heart | Q38253911 | ||
| MicroRNAs in myocardial infarction | Q38289373 | ||
| The Intricate Interplay between Mechanisms Underlying Aging and Cancer | Q38346325 | ||
| The different expression profiles of microRNAs in elderly and young human dental pulp and the role of miR-433 in human dental pulp cells | Q38465674 | ||
| NF-κB activation impairs somatic cell reprogramming in ageing | Q38848975 | ||
| Inhibition of MDA-MB-231 breast cancer cell migration and invasion activity by andrographolide via suppression of nuclear factor-κB-dependent matrix metalloproteinase-9 expression | Q38942339 | ||
| The inhibition of miR-21 promotes apoptosis and chemosensitivity in ovarian cancer | Q39029645 | ||
| MiR-145 is downregulated in human ovarian cancer and modulates cell growth and invasion by targeting p70S6K1 and MUC1. | Q39070970 | ||
| Regulation of UHRF1 by miR-146a/b modulates gastric cancer invasion and metastasis | Q39104253 | ||
| MiR-15a is underexpressed and inhibits the cell cycle by targeting CCNE1 in breast cancer | Q39117821 | ||
| MicroRNA-19a-3p inhibits breast cancer progression and metastasis by inducing macrophage polarization through downregulated expression of Fra-1 proto-oncogene | Q39129449 | ||
| MiR-34a inhibits proliferation and migration of breast cancer through down-regulation of Bcl-2 and SIRT1. | Q39343253 | ||
| MicroRNA-125b induces cancer cell apoptosis through suppression of Bcl-2 expression | Q39403675 | ||
| miR-125b is methylated and functions as a tumor suppressor by regulating the ETS1 proto-oncogene in human invasive breast cancer. | Q39569218 | ||
| Global identification of miR-373-regulated genes in breast cancer by quantitative proteomics | Q39602023 | ||
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 85 | |
| P577 | publication date | 2015-01-01 | |
| P1433 | published in | Frontiers in Medicine | Q27726181 |
| P1476 | title | Inflamma-miRs in Aging and Breast Cancer: Are They Reliable Players? | |
| P478 | volume | 2 |
| Q92134471 | An Emerging Class of Long Non-coding RNA With Oncogenic Role Arises From the snoRNA Host Genes |
| Q91081388 | Dynamic role of the codon 72 p53 single-nucleotide polymorphism in mammary tumorigenesis in a humanized mouse model |
| Q39016000 | Exploring New Inflammatory Biomarkers and Pathways during LPS-Induced M1 Polarization |
| Q96136915 | Implications of Long Non-Coding RNAs in Age-Altered Proteostasis |
| Q49569654 | Landscape of genome-wide age-related DNA methylation in breast tissue |
| Q38732775 | Non-coding RNAs, the Trojan horse in two-way communication between tumor and stroma in colorectal and hepatocellular carcinoma |
| Q39000232 | Novel insight into triple-negative breast cancers, the emerging role of angiogenesis, and antiangiogenic therapy |
| Q52729619 | The Unforeseen Non-Coding RNAs in Head and Neck Cancer. |
| Q60921827 | miR-181a/b therapy in lung cancer: reality or myth? |
Search more.